$REGN News Article - Positive Phase 3 Dupixent (d
Post# of 109
(Total Views: 239)
Posted On: 12/13/2021 8:35:48 AM
$REGN News Article - Positive Phase 3 Dupixent (dupilumab) Data in Children 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis Featured in RAD 2021 Late-breaking Session https://marketwirenews.com/news-releases/posi...14271.html
(0)
(0)Regeneron Pharmaceuticals (REGN) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼